drugset / Trial / NCT05191745

Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery

NCT05191745

Phase 3 Completed 60 enrolled Jewish General Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a randomized, double-blind, controlled clinical trial is to evaluate the duration of efficacy of parasternal blocks with the use of local anesthetic adjuncts for analgesia after coronary artery bypass grafting surgery.

Timeline

Start
2022-01-26
Primary completion
2023-04-28
Completion
2024-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Dexamethasone Small molecule 5 mg Other
Subject Dexmedetomidine Other / unclassified 50 ug Other
Subject Epinephrine Other / unclassified Other

Indications

No indication recorded.